QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.029348v1 71/4/976    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Related articles in MolPharm Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDonald, N. A. Articles by Irving, A. J. Search for Related Content PubMed PubMed Citation Articles by McDonald, N. A. Articles by Irving, A. J.

An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB₁ Cannabinoid Receptor

Neurosciences Institute, Division of Pathology & Neuroscience, Ninewells Hospital & Medical School, University of Dundee, Dundee, Scotland, United Kingdom

In central neurons, the cell-surface distribution of cannabinoid receptor subtype-1 (CB₁) is highly polarized toward axons and is associated with synaptic terminals, in which it is well-positioned to modulate neurotransmitter release. It has been suggested that high levels of constitutive activity mediate CB₁ receptor axonal targeting, leading to domain-specific endocytosis. We have investigated further the mechanisms that underlie CB₁ receptor axonal polarization in hippocampal neurons and found that constitutive activity is not an essential requirement for this process. We demonstrate that the cell-surface distribution of an N-terminally tagged, fluorescent CB₁ receptor fusion-protein is almost exclusively localized to the axon when expressed in cultured hippocampal neurons. Inhibition of endocytosis by cotransfection with a dominant-negative dynamin-1 (K44A) mutant traps both recombinant and endogenous CB₁ receptors at the somatodendritic cell surface. However, this effect could not be mimicked by inhibiting constitutive activity or receptor activation, either by expressing mutant receptors that lack these properties or by treatment with CB₁ receptor antagonists possessing inverse agonist activity. These data are consistent with a revised model in which domain-specific endocytosis regulates the functional polarization of CB₁ receptors, but this process is distinct from constitutive activity.

Address correspondence to: Dr. Andrew Irving, Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY. E-mail: a.j.irving{at}dundee.ac.uk

Related articles in MolPharm:

Constitutive Trafficking—More Than Just Running in Circles?

Laura M. Bohn
MolPharm 2007 71: 957-958. [Abstract] [Full Text]  

This article has been cited by other articles:

				R. Rozenfeld and L. A. Devi Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3 FASEB J, July 1, 2008; 22(7): 2311 - 2322. [Abstract] [Full Text] [PDF]

				M. Canals and G. Milligan Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors J. Biol. Chem., April 25, 2008; 283(17): 11424 - 11434. [Abstract] [Full Text] [PDF]

				N. D. Holliday, B. Holst, E. A. Rodionova, T. W. Schwartz, and H. M. Cox Importance of Constitutive Activity and Arrestin-Independent Mechanisms for Intracellular Trafficking of the Ghrelin Receptor Mol. Endocrinol., December 1, 2007; 21(12): 3100 - 3112. [Abstract] [Full Text] [PDF]

				J. L. Niehaus, Y. Liu, K. T. Wallis, M. Egertova, S. G. Bhartur, S. Mukhopadhyay, S. Shi, H. He, D. E. Selley, A. C. Howlett, et al. CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a Mol. Pharmacol., December 1, 2007; 72(6): 1557 - 1566. [Abstract] [Full Text] [PDF]

				L. M. Bohn Constitutive Trafficking--More Than Just Running in Circles? Mol. Pharmacol., April 1, 2007; 71(4): 957 - 958. [Abstract] [Full Text] [PDF]